Mary Ann Anderson
I graduated MBBS from Melbourne University in 2003 and undertook physician and haematology training in Melbourne finishing in 2011. Since 2011 I have undertaken PhD studies and now further post graduate research in the field of targeted therapy for blood cancer. My current research interests are:
(1) Establishing biomarkers for response to BH3 mimetic therapy
(2) Understanding mechanisms for resistance to targeted therapy
(3) Translating new laboratory discoveries into clinical care for patients
Abstracts this author is presenting:
